Shurink Universe vs Ulthera (2026): How Korean HIFU Platforms Actually Differ

Shurink Universe and Ulthera are both focused ultrasound skin tightening platforms, and the practical difference between them is real-time ultrasound imaging: Ulthera visualises the tissue layers before energy is delivered, while Shurink Universe does not. Updated 18 September 2026. Korean Plastic Surgery Research Desk. Korean clinics offer both, frequently at markedly different prices, and patients are rarely told what the price gap represents. This guide explains how the technology works, where the two platforms genuinely diverge, where they do not, and how to judge which is appropriate for you.

How focused ultrasound tightening works

High-intensity focused ultrasound for aesthetic use concentrates acoustic energy at a predetermined depth beneath the skin surface, producing small discrete zones of thermal effect in the target layer while the overlying epidermis is comparatively spared. The intended response is tissue contraction at the point of treatment followed by a wound healing and remodelling process, which is generally described as developing gradually over the following weeks to months. Treatment depth is set by the transducer cartridge selected, with commonly used depths of approximately 4.5mm, 3.0mm and 1.5mm targeting different tissue planes from the deeper fibromuscular layer through to the dermis. This is the shared mechanism. Both platforms discussed here operate on it, which is why comparisons framed as one technology against another are misleading. The comparison is between implementations.

What Ulthera adds: imaging before energy

Ulthera, developed by Ulthera Inc. and now part of Merz Aesthetics, is generally described as micro-focused ultrasound with visualisation. The distinguishing feature is a real-time imaging function allowing the operator to see the tissue layers on screen before delivering energy, and to confirm that the intended plane is being targeted at the selected depth. The clinical rationale is twofold. It allows the operator to verify placement in an individual patient whose tissue thickness differs from the average, and it allows avoidance of structures where energy delivery is undesirable, notably over bone where the tissue is thin. Ulthera has a long presence in the international aesthetic market and holds regulatory clearances in multiple jurisdictions including the United States for specified lifting indications. This history and the imaging function are the principal justifications offered for its higher price.

What Shurink Universe offers

Shurink Universe is manufactured by CLASSYS, a Korean medical device company, and was introduced at the KIMES exhibition in 2021 as a successor within the established Shurink line. It delivers focused ultrasound through interchangeable cartridges at the standard treatment depths and is cleared by the Korean regulator for aesthetic use. It does not incorporate the real-time visualisation function. Its practical advantages in the Korean market are cost and availability: it is widely installed across Korean clinics, and per-session pricing is generally substantially lower than for Ulthera, which makes a full course of treatment or regular maintenance more affordable. For a patient with typical tissue characteristics being treated by an experienced operator working to a standard protocol, this is a legitimate and widely used option rather than a compromised one.

Where the difference actually matters

Visualisation matters most where anatomy departs from the average. Patients with notably thin skin, low subcutaneous fat, or prominent bony structure are the group in whom depth selection carries the least margin for error, and in whom the ability to confirm the plane before firing is most valuable. It also matters in the periorbital and temporal regions and near the mandibular border, where the distance between target tissue and structures best left untreated is smallest. Conversely, in a patient with average tissue thickness receiving treatment to the mid and lower face by an experienced operator, the practical difference between a visualised and non-visualised treatment is likely to be smaller than the marketing suggests. The honest summary is that imaging reduces reliance on the operator's judgement of depth. Where that judgement is well developed, the margin narrows.

Operator skill, settings and shot count

Across both platforms, the variables that most influence outcome are not the badge on the machine. They are the number of shots delivered, the depths and energy settings selected, the anatomical mapping of where energy is placed, and the operator's experience. A low shot count at low energy on either device will underdeliver, and clinics competing on headline price sometimes achieve that price by reducing shot count rather than by discounting. Ask how many shots are included, at which depths, and who performs the treatment. In Korea, energy-based treatments may be delivered by a physician or, under differing arrangements, by other staff, and this varies by clinic. Establishing who will hold the handpiece and what their experience is will tell you more about your likely result than a comparison of the two device names.

Choosing between them

A reasonable approach runs as follows. Establish first whether focused ultrasound is the right modality at all, since laxity that has progressed beyond a certain point is generally better addressed surgically, and energy-based tightening cannot substitute for a facelift in an appropriate surgical candidate. If ultrasound is suitable, consider Ulthera where your anatomy is atypical, where the treatment area includes higher-risk zones, or where you place value on documented international regulatory history. Consider Shurink Universe where anatomy is typical, the operator is experienced, and affordability allows an adequate shot count or a maintenance schedule that a single expensive session would not. Comparing an adequately dosed treatment on the less costly platform against an underdosed treatment on the more costly one is the comparison that actually determines value.

Frequently asked questions

Does either device produce a permanent result?

No. Both are generally described as producing a gradual tightening effect that develops over months and then diminishes as ageing continues, with maintenance treatment typically discussed in terms of an annual or similar interval. Any clinic presenting a permanent outcome is overstating what this class of treatment does.

Which one is more painful?

Discomfort with focused ultrasound relates chiefly to energy setting and treatment depth rather than to the brand, with deeper cartridges generally reported as more uncomfortable. Topical anaesthesia and analgesia are commonly used. A treatment reported as entirely painless may indicate energy settings too low to achieve the intended effect.

Can focused ultrasound replace a facelift?

It cannot. Energy-based tightening is generally appropriate for mild to moderate laxity. Where skin excess is significant, surgical repositioning and removal of tissue addresses a problem that no non-surgical device is designed to solve, and a realistic consultation should say so directly.

Are there risks?

Reported effects include redness, swelling, tenderness and temporary numbness. Less common but recognised risks include nerve-related effects such as temporary weakness or altered sensation, burns, and unwanted loss of facial fat, all of which relate to energy delivered at an inappropriate depth or location. This is why operator experience is the central safety variable.

Before you book

Ask which platform will be used, how many shots at which depths are included, who will perform the treatment and what their experience is, and what the total cost of an adequate course would be rather than the headline price of one session. Ask the clinician to assess whether your degree of laxity is suited to a non-surgical approach at all. Sources consulted for this guide include CLASSYS and Merz Aesthetics published product information, the Korea Health Industry Development Institute, the Korean Medical Association, the Korean Society of Plastic and Reconstructive Surgeons and peer-reviewed literature indexed in PubMed. This article is general information and is not a substitute for an individual consultation with a qualified physician.